We welcome O’Ryan and colleagues’ introspective tone and call for a “global conversation” on academia’s role in healthcare.1 Their article resonates with our thoughts and experiences in pain ...

Ahead of this weekend's Super Bowl, some good news for the athletes: NFL players are largely avoiding opioid-based pain ...

New research from McGill University reveals that listening to music at your own rhythm can significantly reduce pain.

When THC attaches to the receptor, the effect is like an off switch to a light bulb, effectively turning "off" the pain. But ...

While New Orleans prepares for the excitement of the big game, it’s important to remember that sports injuries aren’t limited to the professionals. High school athletes, weekend warriors, and generall ...

Dr. Sanjay Gupta said Tuesday that the approval of a new non-opioid pain medication is “a pretty big deal.” “This is a pretty ...

Librela (bedinvetmab injection) is a monthly injectable monoclonal antibody, for which real-world drug experience data has ...

New gene therapies could transform sickle cell treatment forever. A future without pain crises or hospitalizations may finally be within reach.

China Universal Asset Management Co. Ltd. boosted its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) ...

The FDA has approved a new non-opioid prescription medication, Journavx for adults with moderate to severe acute pain.

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...

The new FDA-approved pain drug is suzetrigine, with the brand name Journavx. Suzetrigine is designed to alleviate moderate to ...